IMPORTANT Neurotrope, Inc. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Neurotrope, Inc. 

World News: . []

NEW YORK, May 19, 2017 (GLOBE NEWSWIRE) --  announces that a class action lawsuit has been filed against Neurotrope, Inc. ("Neurotrope" or the "Company") (NASDAQ:NTRP) in the United States District Court for the Southern District of New York on behalf of shareholders who purchased Neurotrope securities between January 7, 2016, and April 28, 2017, both dates inclusive (the "Class Period").

The filed Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose material adverse information regarding the efficacy of its lead product candidate, Bryostatin-1.

On May 1, 2017, Neurotrope announced of the focal Phase 2b trials of Bryostatin-1, mentioning The trial data allegedly negates these statements, as the top-line data relating to the 20 microgram dose of Bryostatin-1 did not produce statistically significant results. Neurotrope also allegedly failed to disclose statements about the efficacy of the 40 microgram dose in connection with its primary and secondary endpoints.

Following this news, Neurotrope stock dropped from a close of $18.81 per share on April 28, 2017, to close at $6.97 per share on May 1, 2017, the subsequent trading day.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact by telephone at (800) 575-0735, via e-mail at , or visit our website at .

## Follow the firm and learn about newly filed cases on and . ##

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: gstone@whafh.com, kcooper@whafh.com or classmember@whafh.com
Tel: (800) 575-0735 or (212) 545-4774

Attorney Advertising. Prior results do not guarantee or predict a similar outcome.

More news and information about Wolf Haldenstein Adler Freeman & Herz LLP

Published By:

Globe Newswire: 21:48 GMT Friday 19th May 2017

Published: .

Search for other references to "important" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2017. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers